Protein-protein interactions for cancer therapy
- PMID: 16452164
- PMCID: PMC1413676
- DOI: 10.1073/pnas.0510948103
Protein-protein interactions for cancer therapy
Conflict of interest statement
Conflict of interest statement: No conflicts declared.
Figures
Comment on
-
Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy.Proc Natl Acad Sci U S A. 2006 Feb 7;103(6):1888-93. doi: 10.1073/pnas.0507493103. Epub 2006 Jan 27. Proc Natl Acad Sci U S A. 2006. PMID: 16443686 Free PMC article.
References
-
- Hollstein M., Sidransky D., Vogelstein B., Harris C. C. Science. 1991;253:49–53. - PubMed
-
- Hainaut P., Hollstein M. Adv. Cancer Res. 2000;77:81–137. - PubMed
-
- Vogelstein B., Lane D., Levine A. J. Nature. 2000;408:307–310. - PubMed
-
- Bond G. L., Hu W., Levine A. J. Curr. Cancer Drug Targets. 2005;5:3–8. - PubMed
-
- Fischer P. M., Lane D. P. Trends Pharmacol. Sci. 2004;25:343–346. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
